Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2022-01589 | Registry Identifier | CTRP (Clinical Trial Reporting Program) | |
| 21-000913 | Other Identifier | Mayo Clinic in Florida |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study evaluates whether clinical evaluation tools such as the six-minute walk test, hand grip strength test, and gait speed test, are useful in predicting risk of complications in patients undergoing hematopoietic stem cell transplants (HCT). Being able to predict who is at increased risk of post-HCT complications can help better inform patients and providers on the risks and benefits of undergoing HCT and determine whether certain patients should have closer post-HCT monitoring due to an increased risk of complications.
PRIMARY OBJECTIVE:
I. To develop novel pre-transplant tools for determining risk of post-HCT pulmonary complications.
OUTLINE: This is an observational study.
Patients undergo a clinical evaluation consisting of a six-minute walk test, hand grip strength test, and gait speed test on study. Patients' medical records are also reviewed for a year on study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Observational (clinical evaluation, record review) | Patients undergo a clinical evaluation consisting of a six-minute walk test, hand grip strength test, and gait speed test on study. Patients' medical records are also reviewed for a year on study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Clinical Evaluation | Other | Undergo clinical evaluation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pulmonary complication following hematopoietic stem cell transplant (HCT) | Pulmonary complications may include but are not limited to: infection, HCT-specific lung injury syndromes, acute respiratory distress syndrome, pulmonary graft versus host disease. Univariable analysis will be first used to identify potential factors that predict post-HCT pulmonary complications. All possible factors will then be included in multivariable analysis. Will also specifically test whether the six-minute walk test, grip strength and gait speed add additional significance to pulmonary complications and the statistic model after including pulmonary function test results. | Up to 1 year after transplant |
| Measure | Description | Time Frame |
|---|---|---|
| 100-day mortality | Analyses similar to those for the primary outcome will be conducted. | At 100 days after transplant |
| 1 year mortality | Analyses similar to those for the primary outcome will be conducted. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adult patients undergoing evaluation for autologous or allogeneic bone marrow transplant.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hemang Yadav, MD | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | United States |
Not provided
| Label | URL |
|---|---|
| Mayo Clinic Clinical Trials | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
| Electronic Health Record Review | Other | Medical records reviewed |
|
| At 1 year after transplant |
| Relapse-free survival | Analyses similar to those for the primary outcome will be conducted. | At 1 year after transplant |
| Hospital or intensive care unit admission post-HCT | Will specifically test whether the six-minute walk test, grip strength and gait speed add additional significance to pulmonary complications and the statistic model after including pulmonary function test results. | Up to 1 year after transplant |
| Need for noninvasive or invasive mechanical ventilation | Will specifically test whether the six-minute walk test, grip strength and gait speed add additional significance to pulmonary complications and the statistic model after including pulmonary function test results. | Up to 1 year after transplant |